Aisling Capital Management’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-17,500
| Closed | -$460K | – | 17 |
|
|
2022
Q3 | $460K | Sell |
17,500
-50,792
| -74% | -$1.34M | 0.31% | 17 |
|
|
2022
Q2 | $3.08M | Hold |
68,292
| – | – | 2.2% | 9 |
|
|
2022
Q1 | $6.72M | Hold |
68,292
| – | – | 3.63% | 8 |
|
|
2021
Q4 | $10.4M | Hold |
68,292
| – | – | 3.68% | 7 |
|
|
2021
Q3 | $9.26M | Hold |
68,292
| – | – | 1.85% | 10 |
|
|
2021
Q2 | $10M | Buy |
+68,292
| New | +$10M | 1.61% | 12 |
|